Showing 35,231 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Hepatitis C treatment

Treatment with DAAs reduces the risk of mortality in the first 18 months after the completion of treatment

News
10 August 2017
Changing treatment

Switch from boosted protease inhibitor to dolutegravir reduces lipids in people with HIV at higher risk of heart disease

News
9 August 2017
Hepatitis B

UK rations hepatitis B vaccine amid global shortage

Editor's pick
BBC Health
8 August 2017
New & experimental HIV treatments

Boosted darunavir plus lamivudine matches three-drug regimen

News
8 August 2017
PrEP

Can new 'Smart PrEP Pills' increase adherence for HIV-prevention medication among young people?

Editor's pick
Chicago Daily Herald
8 August 2017
Viral load

Single measures of viral load not effective for assessing HIV suppression status

Editor's pick
Healio
8 August 2017
PrEP

In first, healthcare provider to subsidize HIV medication

Editor's pick
The Times of Israel
8 August 2017
Pharmaceutical industry

AbbVie Mavyret Price Threatens Gilead Hepatitis Dominance

Editor's pick
Bloomberg
7 August 2017
New & experimental hepatitis C treatment

European and US regulators approve AbbVie's new combo for all hepatitis C genotypes

News
7 August 2017
PrEP

Breakthrough HIV drug: Authorities reconsider decision to block cheap access

Editor's pick
The Sydney Morning Herald
7 August 2017
HIV prevention policy

Government could end HIV transmission in Australia with just $32m year

Editor's pick
The Sydney Morning Herald
7 August 2017
Men who have sex with men (MSM)

Indonesia cracks down on gays ... and fuels its HIV epidemic

Editor's pick
South China Morning Post
7 August 2017
Money

Insurers told to catch up on advances in HIV treatment and other medical conditions

Editor's pick
The Independent
7 August 2017
PrEP

Anti-HIV drug may not come under HSE scheme until 2019

Editor's pick
Irish Times
7 August 2017
PrEP policies & guidelines

Demand for access to NHS PrEP trial looks set to outstrip places

News
4 August 2017
PrEP programmes & uptake

PrEP demand in England is rapidly accelerating – and most will want to join the trial

News
4 August 2017
Pharmaceutical industry

Mylan to Provide Generic Truvada for U.K. Trial

Editor's pick
Wall Street Journal
3 August 2017
PrEP

Controversial PrEP study from NHS England due to start in September

Editor's pick
HIV i-Base
3 August 2017
Experiences of stigma

Insurer Denies Truvada Due to ‘High Risk Homosexual Behavior’

Editor's pick
My Fabulous Disease
3 August 2017
PrEP

NHS England announces world’s largest single PrEP implementation trial to prevent HIV infection

Editor's pick
NHS England
3 August 2017
Sexual health

Sexual health services 'at tipping point' in England

Editor's pick
BBC Health
3 August 2017
The search for a cure

What marks out HIV controllers from others?

News
3 August 2017
The search for a cure

Why curing HIV may be like curing cancer – and may be as difficult

News
3 August 2017
The search for a cure

Can we achieve a complete HIV cure in more patients?

News
3 August 2017